Anebulo Pharmaceuticals (ANEB US)

Anebulo Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing disruptive treatments for substance use disorders, such as cannabinoid overdose and the broader addiction landscape. Anebulo Pharmaceuticals serves customers in the United States.